Medical Utilization & Costs
GLP-1 drug spending, healthcare utilization, and estimated cost savings.
Adjustable GLP-1 drug cost
Total GLP-1 spending = 18,024 member-months × $450 = $8.11M
Healthcare utilization & costs
per 1,000 member-years · $/member/year| Category | Utilization (before → after) | Change | Cost before | Cost after |
|---|---|---|---|---|
| Inpatient admissions | 80 → 76 | -5% | $1,600 | $1,520 |
| Emergency department | 300 → 285 | -5% | $450 | $427.5 |
| Outpatient care | 4000 → 4200 | +5% | $800 | $840 |
| Other prescription drugs | — | -2% | $600 | $588 |
Utilization rates per 1,000 member-years. Healthcare costs per member per year. Outpatient utilization may increase where appropriate (monitoring and follow-up care).
Medical Offsets
ModeledModeled healthcare cost reductions attributable to GLP-1 treatment among active program participants. Excludes GLP-1 drug costs. Not validated.
Total medical & pharmacy spending
Combines total GLP-1 spending with medical offsets for the same population and reporting period. Change versus the relevant comparison includes any GLP-1 spending already present in that comparison.
All utilization and cost figures are illustrative. Savings are estimated from follow-up spending vs. expected spending without the program. Distinguish modeled estimates from validated results.
Employee Privacy Protected by Design
Employer reporting is designed to present aggregate workforce and health-program insights without exposing individual clinical records. Small-group reporting restrictions help reduce the risk of employee identification.
Aggregated information is not described as HIPAA-de-identified unless applicable de-identification requirements have been satisfied and verified.